FDA Approves Lilly's Foundayo for Weight Loss — South Africa Eyes Access
The US Food and Drug Administration (FDA) has approved Eli Lilly’s Foundayo™ (orforglipron), the first once-daily GLP-1 receptor agonist pill for weight loss that does not require food or water res…